Table 4.
Final reduced logistic regression models for the overall population (n = 37) and patients with secure PD medication (n = 29).
| Crude Model | Adjusted Model | |||||||
|---|---|---|---|---|---|---|---|---|
| B | p-Value | Exp(B) | 95% CI for Exp(B) | B | p-Value | Exp(B) | 95% CI for Exp(B) | |
| Model 1—Overall population (n = 37) 1 | ||||||||
| WBC count (109/L) | 0.773 | 0.025 | 2.1 | 1.1–4.2 | 0.773 | 0.025 | 2.2 | 1.1–4.3 |
| Model 2—Secure PD medication (n = 29) 2 | ||||||||
| Gender (male) | 5.064 | 0.024 | 158.3 | 2.0–12760.6 | 5.126 | 0.026 | 19.2 | 1.2–297.1 |
| Segmented neutrophils (109/L) | 3.727 | 0.090 | 41.6 | 0.6–3069.7 | 4.232 | 0.027 | 14.2 | 1.57–128.8 |
| 25OHD2 (nmol/L) | −0.130 | 0.058 | 0.9 | 0.8–1.0 | −0.127 | 0.060 | 0.9 | 0.8–1.0 |
1 R2(n) = 0.291, % correct classification = 75.0%. 2 R2(n) = 0.730, % correct classification = 89.7%. B—unstandardized regression coefficient; WBC—White Blood Cells.